| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R |
| P698 | PubMed publication ID | 29711793 |
| P2093 | author name string | Andrew M Davis | |
| Simon J Teague | |||
| P433 | issue | 6 | |
| P304 | page(s) | 736-749 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
| P1476 | title | Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis | |
| P478 | volume | 38 |
| Q46639902 | (Thermo)dynamic role of receptor flexibility, entropy, and motional correlation in protein-ligand binding |
| Q64114044 | A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods |
| Q37719514 | A medicinal chemist's guide to molecular interactions |
| Q24300837 | A proline to glycine mutation in the Lck SH3-domain affects conformational sampling and increases ligand binding affinity |
| Q58232138 | An Iterative Approach tocis-Oligodiacetylenes |
| Q36838120 | An improved relaxed complex scheme for receptor flexibility in computer-aided drug design |
| Q27631837 | Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking |
| Q33817798 | BINANA: a novel algorithm for ligand-binding characterization |
| Q27679245 | Blind Prediction of Charged Ligand Binding Affinities in a Model Binding Site |
| Q35263970 | CSAR benchmark exercise of 2010: combined evaluation across all submitted scoring functions. |
| Q45973729 | Characterisation of mixed lithium dodecyl sulphate/lithium perfluorooctanesulphonate pseudo-stationary phases in MEKC. |
| Q33179633 | Charge conductivity in peptides: dynamic simulations of a bifunctional model supporting experimental data. |
| Q34604753 | Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective |
| Q79314147 | Deconstructing fragment-based inhibitor discovery |
| Q44207170 | Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm |
| Q37732202 | Dissection of the critical binding determinants of cellular retinoic acid binding protein II by mutagenesis and fluorescence binding assay |
| Q92929102 | Effects of Solvent Properties on the Anion Binding of Neutral Water-Soluble Bis(cyclopeptides) in Water and Aqueous Solvent Mixtures |
| Q27656422 | Elucidating the exact role of engineered CRABPII residues for the formation of a retinal protonated Schiff base |
| Q30336189 | Energetics of hydrogen bonds in peptides. |
| Q99403216 | General Method for Peptide Recognition in Water through Bioinspired Complementarity |
| Q28478884 | Global analysis of small molecule binding to related protein targets |
| Q34006658 | HBonanza: a computer algorithm for molecular-dynamics-trajectory hydrogen-bond analysis |
| Q27728018 | Hydrogen Bonding of 1,2-Azaborines in the Binding Cavity of T4 Lysozyme Mutants: Structures and Thermodynamics |
| Q46146825 | Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors |
| Q35541964 | Identification of protein-ligand binding sites by the level-set variational implicit-solvent approach |
| Q35167908 | Implications of protein flexibility for drug discovery |
| Q35419556 | Inclusion of solvation and entropy in the knowledge-based scoring function for protein-ligand interactions |
| Q36803157 | Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents |
| Q42234866 | Interactions between photoacidic 3-hydroxynaphtho[1,2-b]quinolizinium and cucurbit[7]uril: Influence on acidity in the ground and excited state |
| Q31035874 | Library generation via postcondensation modifications of isocyanide-based multicomponent reactions |
| Q37212415 | Limitations and lessons in the use of X-ray structural information in drug design |
| Q36300605 | Measurements of binding thermodynamics in drug discovery |
| Q45268242 | Micellar proportion: a parameter to compare the hydrophobicity of the pseudostationary phases or that of the analytes in micellar electrokinetic chromatography |
| Q33459531 | Modelling substrate specificity and enantioselectivity for lipases and esterases by substrate-imprinted docking |
| Q98945283 | Molecular docking data of piperine with Bax, Caspase 3, Cox 2 and Caspase 9 |
| Q91994595 | Multi-Target β-Protease Inhibitors from Andrographis paniculata: In Silico and In Vitro Studies |
| Q33957650 | Oestrogenic activity of parabens in MCF7 human breast cancer cells |
| Q60195780 | Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase1,21Escherichia coli thymidylate synthase numbering is used unless otherwise noted.2PDB coordinates have been deposited with the RCSB wi |
| Q33966894 | Probing ligand-binding pockets of the mevalonate pathway enzymes from Streptococcus pneumoniae |
| Q37094819 | Protein dynamics and the immunological evolution of molecular recognition. |
| Q41633463 | Quantum mechanics implementation in drug-design workflows: does it really help? |
| Q34029153 | Recent advances in structure-based rational drug design. |
| Q28364576 | Reduced antibody response to streptavidin through site-directed mutagenesis |
| Q42048187 | Sexual attraction in the silkworm moth. Nature of binding of bombykol in pheromone binding protein--an ab initio study. |
| Q43552108 | Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides |
| Q34215889 | Statistical potentials and scoring functions applied to protein-ligand binding |
| Q27680709 | Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase |
| Q44030072 | Structure-based design and synthesis of HIV-1 protease inhibitors employing beta-D-mannopyranoside scaffolds |
| Q30478835 | Structure-based engineering of internal cavities in coiled-coil peptides. |
| Q51925540 | Structure-based maximal affinity model predicts small-molecule druggability. |
| Q36647895 | Structure-based organic synthesis of drug prototypes: a personal odyssey |
| Q27638967 | Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes |
| Q30327325 | SymROP: ROP protein with identical helices redesigned by all-atom contact analysis and molecular dynamics. |
| Q49127002 | Synthesis and binding activity of endomorphin-1 analogues containing beta-amino acids. |
| Q61767255 | Synthesis, Biological Evaluation and Docking Studies of Casuarine Analogues: Effects of Structural Modifications at Ring B on Inhibitory Activity Towards Glucoamylase |
| Q43095035 | The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: a biophysical characterization |
| Q41842059 | The discovery of dabigatran etexilate |
| Q51552311 | The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists. |
| Q43932168 | Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis |
| Q33558081 | Vorinostat-like molecules as structural, stereochemical, and pharmacological tools |
Search more.